Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PDSB will decline by -17.48% over the next 2 Weeks and hit $0.56 by Friday, August 7, 2026. In that time frame, PDSB's share price is expected to range between $0.52 and $0.61.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 7, 2026 | 0.53 | 0.57 | 0.62 |
| Aug 6, 2026 | 0.57 | 0.61 | 0.66 |
| Aug 5, 2026 | 0.55 | 0.59 | 0.64 |
| Aug 4, 2026 | 0.57 | 0.61 | 0.66 |
| Aug 3, 2026 | 0.57 | 0.62 | 0.66 |
| Jul 31, 2026 | 0.58 | 0.63 | 0.67 |
| Jul 30, 2026 | 0.62 | 0.67 | 0.71 |
| Jul 29, 2026 | 0.60 | 0.65 | 0.70 |
| Jul 28, 2026 | 0.62 | 0.67 | 0.71 |
| Jul 27, 2026 | 0.63 | 0.67 | 0.72 |
PDSB shares rose +1.66% in Monday, July 27, 2026's trading session, rising from a previous close of $0.68 to move at $0.69. The stock demonstrated notable intraday movement (see PDSB's key stats for a full breakdown), fluctuating between $0.65 and $0.72, a +9.98% trading range. While recent weeks have seen some volatility, PDSB has managed to secure a -7.89% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 363.08K shares changing hands, 161.03K more than the previous session. This amounted to $251.50K in total market activity.
Will PDSB Continue Its Downward Trend?
According to analyst ratings and projections for PDSB, PDS Biotechnology Corporation shares are anticipated to decrease by -12.47%, potentially reaching $0.62 per share by August 7, 2026. Short-term technical indicators currently suggest a neutral sentiment for PDSB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 7 positive trading days within the past 30 sessions. Based on the PDSB stock forecast, now is not the best time to buy PDSB stock because its current trading price is +21.33% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on PDSB covering social and institutional perspectives.
PDSB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PDSB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 31.67% to 37.65%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 45.05%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.84%, maintains a neutral outlook for the long term. Insights into PDSB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
PDS Biotechnology Short-Term Forecasts
PDSB Forecast For Next 5 Days
Our algorithm anticipates PDS Biotechnology (PDSB) stock could hit $0.58 by Aug 03, 2026. This represents a -15.56% fall from today's price, following a -3.48% change over the past five days.
PDSB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for PDS Biotechnology Corporation (PDSB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.55, which would mean a -20.60% decrease from the current price of $0.69. Projections for this period range from a high of $0.75 to a low of $0.35.
PDSB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for PDS Biotechnology's price over the next three months point to a rise. PDSB stock is expected to peak at $2.42 on Jul 31, 2026 before potentially dipping to $1.02 on Sep 21, 2026. On average, PDSB is likely to trade around $1.92 in the coming 90 days.
PDS Biotechnology Stock Forecast 2025
Based on our predictive models, PDS Biotechnology (PDSB) is expected to trade between $1.02 and $3.21 throughout 2026. This would result in an average price of $2.14, potentially offering investors a +208.94% return from current levels.
PDS Biotechnology Corporation Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, PDS Biotechnology Corporation (PDSB) is positioned to show a strong performance in July 2026. The price is predicted to move between $2.07 and $2.42, settling at an average of $2.26. This could translate to a +226.26% gain.
August 2026
Based on current market signals, PDS Biotechnology Corporation is projected to trend august 2026. We forecast a trading range from $1.71 to $2.42, with a likely average price of $2.01. Investors could expect a potential return of +190.17%.
September 2026
Our predictive algorithms indicate PDS Biotechnology Corporation stock may see a shift in September 2026. The expected range spans $1.02–$2.07, with an average target of $1.65. This represents a positive outlook and a possible gain of +138.20%.
October 2026
Analyzing established trends, PDS Biotechnology Corporation looks set to move in October 2026. Projections place the stock between $1.64 and $2.40, averaging around $2.02. This suggests a +191.61% gain from current levels.
November 2026
Market indicators suggest PDS Biotechnology Corporation could experience notable changes during November 2026. Prices could fluctuate within $1.73 to $3.21, with a midpoint forecast of $2.48. The stock might deliver a +258.02% gain.
December 2026
Forecasting for December 2026, models estimate that PDS Biotechnology Corporation may undergo key fluctuations. If trends hold, the stock might trade between $1.49 and $3.06, averaging $2.50. This signals a positive trajectory with potential returns around +260.91%.
January 2027
According to our latest forecast models, PDS Biotechnology Corporation (PDSB) is positioned to show a strong performance in January 2027. The price is predicted to move between $1.07 and $2.87, settling at an average of $2.18. This could translate to a +214.71% gain.
February 2027
Based on current market signals, PDS Biotechnology Corporation is projected to trend february 2027. We forecast a trading range from $0.71 to $2.42, with a likely average price of $1.93. Investors could expect a potential return of +178.62%.
March 2027
Our predictive algorithms indicate PDS Biotechnology Corporation stock may see a shift in March 2027. The expected range spans $0.48–$2.85, with an average target of $2.56. This represents a positive outlook and a possible gain of +269.57%.
April 2027
Analyzing established trends, PDS Biotechnology Corporation looks set to move in April 2027. Projections place the stock between $0.16 and $1.52, averaging around $1.42. This suggests a +104.99% gain from current levels.
May 2027
Market indicators suggest PDS Biotechnology Corporation could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $3.42, with a midpoint forecast of $2.67. The stock might deliver a +285.45% gain.
June 2027
Forecasting for June 2027, models estimate that PDS Biotechnology Corporation may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.24, averaging $2.21. This signals a positive trajectory with potential returns around +219.04%.
July 2027
According to our latest forecast models, PDS Biotechnology Corporation (PDSB) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $2.30, settling at an average of $1.77. This could translate to a +155.52% gain.
PDSB's history of dividends and stock splits also plays a role in long-term investor confidence.

